SIF

Oral Communications Abstracts
C17 - Pharmacology of Pain


NUCLEOTIDE RECEPTORS IN TRIGEMINAL SATELLITE GLIAL CELLS AS NEW TARGETS FOR THE PHARMACOLOGICAL CONTROL OF MIGRAINE PAIN: IN VITRO AND IN VIVO STUDIES.
Magni G., Merli D., Abbracchio M., Ceruti S.
TAPENTADOL MODULATES CALCITONIN GENE-RELATED PEPTIDE RELEASE FROM RAT BRAINSTEM. COMPARISON WITH MORPHINE AND REBOXETINE.
Tringali G., Greco M., Navarra P.
OXALIPLATIN-DEPENDENT APOPTOSIS: DIFFERENT APOPTOTIC PROCESS IN PRIMARY ASTROCYTES VS COLORECTAL CANCER CELLS
Zanardelli M., Di Cesare Mannelli L., Micheli L., Cinci L., Baptista De Souza D., Failli P., Ghelardini C.
THE ROLE FOR NAD+-DEPENDENT SIRT3 DEACETYLASE DURING OPIOID TOLERANCE: A NEW THERAPEUTIC APPROACH FOR NATURAL ANTIOXIDANTS
Lauro F., Ilari S., Dagostino C., Pucci B., Casale F., Gliozzi M., Tafani M., Palma E., Salvemini D., Fini M., Russo M., Mollace V., Muscoli C.
PALMITOYLETHANOLAMIDE REDUCES FORMALIN-INDUCED NEUROPATHIC-LIKE BEHAVIOUR THROUGH SPINAL GLIAL/MICROGLIAL PHENOTYPICAL CHANGES IN MICE
Guida F., Luongo L., Boccella S., Bellini G., Gatta L., Rossi F., de Novellis V., Maione S.
LEPTIN-CONTROLLED OREXIN/ENDOCANNABINOID INTERACTIONS IN THE MOUSE PERIAQUEDUCTAL GREY: ROLE IN THE REGULATION OF THE DESCENDING ANTINOCICEPTIVE PATHWAY
Luongo L., Cristino L., Imperatore R., Boccella S., Giordano M., Petrosino S., Orlando P., Rossi F., Di Marzo V., Maione S.
THE NORADRENERGIC COMPONENT IN TAPENTADOL ACTION COUNTERACTS MOR-MEDIATED ADVERSE EFFECTS ON ADULT NEUROGENESIS
Meneghini V., Cuccurazzu B., Ramazzotti V., Ubezio F., Tzschentke T., Canonico P., Grilli M.